Covid19 Clinical Trial
Official title:
Psychiatric Consultation for COVID-19 Patients
In this study, the content and results of the psychiatric consultation on patients in Corona
Care Ward were verified retroactively, and the effects of COVID-19 patients' emotional state
and psychological support and crisis intervention were assessed on their emotional state.
Patients who are admitted to the COVID-19 care unit of the Catholic University of Daegu
Hospital are subject to consultation with the psychiatrist. By retrospectively reviewing the
medical records of the request and the results of the subjects, We collected
Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings,
medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS,
P4, SF-36, SCL-90-R) This study evaluates whether there is a difference in psychological
scale according to differences in socio-demographic status and medical severity, and compares
psychological measures before and after referral to mental health medicine to evaluate the
effectiveness of psychiatric counseling.
Status | Not yet recruiting |
Enrollment | 54 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: 1. Patient admitted to the COVID-19 management ward of Daegu Catholic University Hospital 2. Patients who were consulted with a psychiatrist by a physician. Exclusion Criteria: 1. When the subject is accompanied by a serious physical or neurological condition 2. In case of brain damage or concussion with loss of consciousness at the time of treatment 3. When it is difficult to understand psychological intervention due to the apparent decrease in intelligence at the time of treatment 4. When it is difficult to understand psychological intervention and follow examination instructions due to noticeable sensory damage such as hearing and vision at the time of treatment |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Daegu Catholic University Medical Center |
Folkman S, Greer S. Promoting psychological well-being in the face of serious illness: when theory, research and practice inform each other. Psychooncology. 2000 Jan-Feb;9(1):11-9. Review. — View Citation
Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, Wang Y, Hu J, Lai J, Ma X, Chen J, Guan L, Wang G, Ma H, Liu Z. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020 Mar;7(3):e14. doi: 10.1016/S2215-0366(20)30047-X. Epub 2020 Feb 5. — View Citation
Lee SM, Kang WS, Cho AR, Kim T, Park JK. Psychological impact of the 2015 MERS outbreak on hospital workers and quarantined hemodialysis patients. Compr Psychiatry. 2018 Nov;87:123-127. doi: 10.1016/j.comppsych.2018.10.003. Epub 2018 Oct 13. — View Citation
Maunder R, Hunter J, Vincent L, Bennett J, Peladeau N, Leszcz M, Sadavoy J, Verhaeghe LM, Steinberg R, Mazzulli T. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. CMAJ. 2003 May 13;168(10):1245-51. — View Citation
Okusaga O, Yolken RH, Langenberg P, Lapidus M, Arling TA, Dickerson FB, Scrandis DA, Severance E, Cabassa JA, Balis T, Postolache TT. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J Affect Disord. 2011 Apr;130(1-2):220-5. doi: 10.1016/j.jad.2010.09.029. Epub 2010 Oct 27. — View Citation
Park SC, Park YC. Mental Health Care Measures in Response to the 2019 Novel Coronavirus Outbreak in Korea. Psychiatry Investig. 2020 Feb;17(2):85-86. doi: 10.30773/pi.2020.0058. Epub 2020 Feb 25. — View Citation
Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020 Mar;7(3):228-229. doi: 10.1016/S2215-0366(20)30046-8. Epub 2020 Feb 4. — View Citation
Xiao C. A Novel Approach of Consultation on 2019 Novel Coronavirus (COVID-19)-Related Psychological and Mental Problems: Structured Letter Therapy. Psychiatry Investig. 2020 Feb;17(2):175-176. doi: 10.30773/pi.2020.0047. Epub 2020 Feb 25. — View Citation
Zhou X. Psychological crisis interventions in Sichuan Province during the 2019 novel coronavirus outbreak. Psychiatry Res. 2020 Feb 26;286:112895. doi: 10.1016/j.psychres.2020.112895. [Epub ahead of print] — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of PHQ-9 (Patient Health Questionnaire-9) | for assess depressive symptom | On admission and at the time of discharge, on average 2 months | |
Primary | Change of GAD-7 (Patient Health Questionnaire-9) | for assess anxiety symptom | On admission and at the time of discharge, on average 2 months | |
Primary | Change of PC-PTSD-5 (Primary Care PTSD Screen for DSM-5) | for assess PTSD symptom | On admission and at the time of discharge, on average 2 months | |
Primary | Change of AIS (Athens Insomnia Scale) | for assess insomnia | On admission and at the time of discharge, on average 2 months | |
Primary | Change of P4 (P4 Suicidality Screener) | for assess suicidal idea | On admission and at the time of discharge, on average 2 months | |
Primary | Change of SF-36 (Short Form Health Survey Questionnaire) | for assess health associated QoL | On admission and at the time of discharge, on average 2 months | |
Secondary | Change of SCL-90-R | for assess other psychiatric symptoms | On admission and at the time of discharge, on average 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |